The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of additional olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting: A randomized, double-blind, placebo-controlled, crossover study.
 
Veerisa Vimolchalao
No Relationships to Disclose
 
Siwat Sakdejayont
No Relationships to Disclose
 
Ploytuangporn Wongchanapai
No Relationships to Disclose
 
Shama Sukprakun
No Relationships to Disclose
 
Suleepon Uttamapinan
No Relationships to Disclose
 
Nattaya Sintawichai
No Relationships to Disclose
 
Nattaya Poovorawan
No Relationships to Disclose
 
Sutima Luangdilok
No Relationships to Disclose
 
Napa Parinyanitikul
No Relationships to Disclose
 
Chanida Vinayanuwattikun
No Relationships to Disclose
 
Virote Sriuranpong
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Eisai; MSD Oncology; Novartis; Roche
Research Funding - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Eisai; MSD Oncology; Sanofi
 
Suebpong Tanasanvimon
No Relationships to Disclose